Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/14/2025

Diagnosis and Management of Polycythemia

Diagnostic Approach

  • Polycythemia should be suspected when hemoglobin/hematocrit is higher than the 95th percentile adjusted for sex and race, or when there is a documented increase in hemoglobin/hematocrit above the patient's baseline, especially in the presence of PV-related features such as thrombocytosis, leukocytosis, microcytosis, splenomegaly, aquagenic pruritus, unusual thrombosis, or erythromelalgia, with borderline-high hematocrit 1
  • A low EPO level is highly suggestive of PV, with a specificity of over 90%, while a normal EPO level does not rule out PV, and an elevated EPO level suggests secondary polycythemia 1
  • Bone marrow examination with cytogenetic studies is essential to differentiate between PV and secondary polycythemia, looking for hypercellularity, increased megakaryocytes with cluster formation, giant megakaryocytes, pleomorphic megakaryocyte morphology, mild reticulin fibrosis, and decreased iron stores 1
  • If JAK2V617F mutation is negative but PV is still suspected, testing for calreticulin mutation is recommended 2

Diagnostic Tests

  • Endogenous erythroid colony assays, PRV-1 expression in peripheral blood neutrophils, and bone marrow c-mpl immunostains can be useful in the diagnosis of PV 1
  • Measurement of arterial hemoglobin-oxygen saturation and carboxyhemoglobin level, especially in smokers, can help identify secondary causes of polycythemia 1
  • Renal vascular studies and imaging studies of the kidney, liver, and central nervous system may be necessary to rule out underlying causes of secondary polycythemia 1

Treatment Approach

  • Treatment of underlying causes, such as smoking cessation for smoker's polycythemia, CPAP for sleep apnea, and treatment of underlying malignancies or benign tumors producing EPO, is essential 1
  • In patients with PV, indefinite anticoagulation is warranted in cases of splanchnic vein thrombosis 2
  • Intractable pruritus may respond to selective serotonin reuptake inhibitors or interferon-α 1

Special Considerations

  • The American College of Physicians recommends against relying solely on red cell mass measurement for the diagnosis of PV, as normal RCM does not rule out PV and RCM measurement with hematocrit >60% is redundant and costly 1
  • Clinicians should be aware of the potential complications of PV, including thrombotic events, bleeding risk, and disease transformation, and consider special situations such as splanchnic vein thrombosis and intractable pruritus [1] [2]